# FDA recall D-1545-2020

> **Hetero Labs Limited (Unit V)** · Class II · drug recall initiated 2020-08-06.

## Product

Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India

## Reason for recall

Failed Tablet/Capsule Specification; complaint of bulging tablet

## Distribution

Product was distributed to major wholesalers/distributors throughout the United States.

## Key facts

- **Recall number:** D-1545-2020
- **Recalling firm:** Hetero Labs Limited (Unit V)
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-08-06
- **Report date:** 2020-09-02
- **Termination date:** 2022-01-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Badepalle, N/A, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1545-2020

## Citation

> AI Analytics. FDA recall D-1545-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1545-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*